491 related articles for article (PubMed ID: 10751437)
21. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
Maeda T; Horiuchi N
J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of eIF2α attenuates statin-induced apoptosis by inhibiting the stabilization and translocation of p53 to the mitochondria.
Lee SK; Kim YS
Int J Oncol; 2013 Mar; 42(3):810-6. PubMed ID: 23354132
[TBL] [Abstract][Full Text] [Related]
24. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
25. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Correll CC; Ng L; Edwards PA
J Biol Chem; 1994 Jul; 269(26):17390-3. PubMed ID: 8021239
[TBL] [Abstract][Full Text] [Related]
26. Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist.
Goto T; Nagai H; Egawa K; Kim YI; Kato S; Taimatsu A; Sakamoto T; Ebisu S; Hohsaka T; Miyagawa H; Murakami S; Takahashi N; Kawada T
Biochem J; 2011 Aug; 438(1):111-9. PubMed ID: 21605082
[TBL] [Abstract][Full Text] [Related]
27. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
28. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
30. Mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase function in alpha-toxin-perforated cells.
Giron MD; Havel CM; Watson JA
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6398-402. PubMed ID: 8022795
[TBL] [Abstract][Full Text] [Related]
31. Isoprenoid synthesis in isolated embryonic Drosophila cells. Sterol-independent regulatory signal molecule is distal to isopentenyl 1-pyrophosphates.
Watson JA; Havel CM; Lobos DV; Baker FC; Morrow CJ
J Biol Chem; 1985 Nov; 260(26):14083-91. PubMed ID: 4055772
[TBL] [Abstract][Full Text] [Related]
32. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.
Michikawa M; Yanagisawa K
J Neurochem; 1999 Jun; 72(6):2278-85. PubMed ID: 10349836
[TBL] [Abstract][Full Text] [Related]
34. A critical role of mevalonate for peptidoglycan synthesis in Staphylococcus aureus.
Matsumoto Y; Yasukawa J; Ishii M; Hayashi Y; Miyazaki S; Sekimizu K
Sci Rep; 2016 Mar; 6():22894. PubMed ID: 26961421
[TBL] [Abstract][Full Text] [Related]
35. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
36. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
Woschek M; Kneip N; Jurida K; Marzi I; Relja B
Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
[TBL] [Abstract][Full Text] [Related]
38. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
Cohen LH; Griffioen M
Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
[TBL] [Abstract][Full Text] [Related]
39. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
40. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
